Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Limestone Health Facility is a Athens, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Morehead Memorial Hospital operates as a community hospital that provides various medical services to patients in Eden, North Carolina. It offers birthing center, cancer center, cardiac rehabilitation and chronic disease management, cardiopulmonary, day hospital, diagnostic imaging, emergency, intensive coronary care unit, laboratory, nursing center, occupational health, rehabilitation, sleep center, diagnostic center, wound healing center, and women’s diagnostic services. The company was founded in 1960 and is headquartered in Eden, North Carolina.
Test Equipment Distributors is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We`re a team of inventors, mothers, fathers, aunties and uncles on a mission to help women live their best lives starting with the Willow Wearable Breast Pump.